Global Insomnia Pharmacological Treatment Market Growth (Status and Outlook) 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Insomnia Pharmacological Treatment market size is predicted to grow from US$ 3059 million in 2025 to US$ 3769 million in 2031; it is expected to grow at a CAGR of 3.5% from 2025 to 2031.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Insomnia Pharmacological Treatment Industry Forecast” looks at past sales and reviews total world Insomnia Pharmacological Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Insomnia Pharmacological Treatment sales for 2025 through 2031. With Insomnia Pharmacological Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Insomnia Pharmacological Treatment industry.
This Insight Report provides a comprehensive analysis of the global Insomnia Pharmacological Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Insomnia Pharmacological Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Insomnia Pharmacological Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Insomnia Pharmacological Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Insomnia Pharmacological Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Insomnia Pharmacological Treatment market by product type, application, key players and key regions and countries.
Segmentation by Type:
The global Insomnia Pharmacological Treatment market size is predicted to grow from US$ 3059 million in 2025 to US$ 3769 million in 2031; it is expected to grow at a CAGR of 3.5% from 2025 to 2031.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Insomnia Pharmacological Treatment Industry Forecast” looks at past sales and reviews total world Insomnia Pharmacological Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Insomnia Pharmacological Treatment sales for 2025 through 2031. With Insomnia Pharmacological Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Insomnia Pharmacological Treatment industry.
This Insight Report provides a comprehensive analysis of the global Insomnia Pharmacological Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Insomnia Pharmacological Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Insomnia Pharmacological Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Insomnia Pharmacological Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Insomnia Pharmacological Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Insomnia Pharmacological Treatment market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Prescription Sleep Aids
- Over-the-Counter Sleep Aids
- Homecare
- Clinic
- Hospital
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Eisai, Co. Ltd. (Japan)
- Merck & Co., Inc (US)
- Meda Consumer Healthcare Inc (US)
- Pfizer, Inc (US)
- Sanofi (France)
- Takeda Pharmaceutical Company Ltd. (Japan)
- Pernix Therapeutics (US)
- Purdue Pharma L.P (US)
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Insomnia Pharmacological Treatment Market Size (2020-2031)
2.1.2 Insomnia Pharmacological Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Insomnia Pharmacological Treatment by Country/Region (2020, 2024 & 2031)
2.2 Insomnia Pharmacological Treatment Segment by Type
2.2.1 Prescription Sleep Aids
2.2.2 Over-the-Counter Sleep Aids
2.3 Insomnia Pharmacological Treatment Market Size by Type
2.3.1 Insomnia Pharmacological Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Insomnia Pharmacological Treatment Market Size Market Share by Type (2020-2025)
2.4 Insomnia Pharmacological Treatment Segment by Application
2.4.1 Homecare
2.4.2 Clinic
2.4.3 Hospital
2.5 Insomnia Pharmacological Treatment Market Size by Application
2.5.1 Insomnia Pharmacological Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Insomnia Pharmacological Treatment Market Size Market Share by Application (2020-2025)
3 INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE BY PLAYER
3.1 Insomnia Pharmacological Treatment Market Size Market Share by Player
3.1.1 Global Insomnia Pharmacological Treatment Revenue by Player (2020-2025)
3.1.2 Global Insomnia Pharmacological Treatment Revenue Market Share by Player (2020-2025)
3.2 Global Insomnia Pharmacological Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 INSOMNIA PHARMACOLOGICAL TREATMENT BY REGION
4.1 Insomnia Pharmacological Treatment Market Size by Region (2020-2025)
4.2 Global Insomnia Pharmacological Treatment Annual Revenue by Country/Region (2020-2025)
4.3 Americas Insomnia Pharmacological Treatment Market Size Growth (2020-2025)
4.4 APAC Insomnia Pharmacological Treatment Market Size Growth (2020-2025)
4.5 Europe Insomnia Pharmacological Treatment Market Size Growth (2020-2025)
4.6 Middle East & Africa Insomnia Pharmacological Treatment Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Insomnia Pharmacological Treatment Market Size by Country (2020-2025)
5.2 Americas Insomnia Pharmacological Treatment Market Size by Type (2020-2025)
5.3 Americas Insomnia Pharmacological Treatment Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Insomnia Pharmacological Treatment Market Size by Region (2020-2025)
6.2 APAC Insomnia Pharmacological Treatment Market Size by Type (2020-2025)
6.3 APAC Insomnia Pharmacological Treatment Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Insomnia Pharmacological Treatment Market Size by Country (2020-2025)
7.2 Europe Insomnia Pharmacological Treatment Market Size by Type (2020-2025)
7.3 Europe Insomnia Pharmacological Treatment Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Insomnia Pharmacological Treatment by Region (2020-2025)
8.2 Middle East & Africa Insomnia Pharmacological Treatment Market Size by Type (2020-2025)
8.3 Middle East & Africa Insomnia Pharmacological Treatment Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET FORECAST
10.1 Global Insomnia Pharmacological Treatment Forecast by Region (2026-2031)
10.1.1 Global Insomnia Pharmacological Treatment Forecast by Region (2026-2031)
10.1.2 Americas Insomnia Pharmacological Treatment Forecast
10.1.3 APAC Insomnia Pharmacological Treatment Forecast
10.1.4 Europe Insomnia Pharmacological Treatment Forecast
10.1.5 Middle East & Africa Insomnia Pharmacological Treatment Forecast
10.2 Americas Insomnia Pharmacological Treatment Forecast by Country (2026-2031)
10.2.1 United States Market Insomnia Pharmacological Treatment Forecast
10.2.2 Canada Market Insomnia Pharmacological Treatment Forecast
10.2.3 Mexico Market Insomnia Pharmacological Treatment Forecast
10.2.4 Brazil Market Insomnia Pharmacological Treatment Forecast
10.3 APAC Insomnia Pharmacological Treatment Forecast by Region (2026-2031)
10.3.1 China Insomnia Pharmacological Treatment Market Forecast
10.3.2 Japan Market Insomnia Pharmacological Treatment Forecast
10.3.3 Korea Market Insomnia Pharmacological Treatment Forecast
10.3.4 Southeast Asia Market Insomnia Pharmacological Treatment Forecast
10.3.5 India Market Insomnia Pharmacological Treatment Forecast
10.3.6 Australia Market Insomnia Pharmacological Treatment Forecast
10.4 Europe Insomnia Pharmacological Treatment Forecast by Country (2026-2031)
10.4.1 Germany Market Insomnia Pharmacological Treatment Forecast
10.4.2 France Market Insomnia Pharmacological Treatment Forecast
10.4.3 UK Market Insomnia Pharmacological Treatment Forecast
10.4.4 Italy Market Insomnia Pharmacological Treatment Forecast
10.4.5 Russia Market Insomnia Pharmacological Treatment Forecast
10.5 Middle East & Africa Insomnia Pharmacological Treatment Forecast by Region (2026-2031)
10.5.1 Egypt Market Insomnia Pharmacological Treatment Forecast
10.5.2 South Africa Market Insomnia Pharmacological Treatment Forecast
10.5.3 Israel Market Insomnia Pharmacological Treatment Forecast
10.5.4 Turkey Market Insomnia Pharmacological Treatment Forecast
10.6 Global Insomnia Pharmacological Treatment Forecast by Type (2026-2031)
10.7 Global Insomnia Pharmacological Treatment Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Insomnia Pharmacological Treatment Forecast
11 KEY PLAYERS ANALYSIS
11.1 Eisai, Co. Ltd. (Japan)
11.1.1 Eisai, Co. Ltd. (Japan) Company Information
11.1.2 Eisai, Co. Ltd. (Japan) Insomnia Pharmacological Treatment Product Offered
11.1.3 Eisai, Co. Ltd. (Japan) Insomnia Pharmacological Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Eisai, Co. Ltd. (Japan) Main Business Overview
11.1.5 Eisai, Co. Ltd. (Japan) Latest Developments
11.2 Merck & Co., Inc (US)
11.2.1 Merck & Co., Inc (US) Company Information
11.2.2 Merck & Co., Inc (US) Insomnia Pharmacological Treatment Product Offered
11.2.3 Merck & Co., Inc (US) Insomnia Pharmacological Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Merck & Co., Inc (US) Main Business Overview
11.2.5 Merck & Co., Inc (US) Latest Developments
11.3 Meda Consumer Healthcare Inc (US)
11.3.1 Meda Consumer Healthcare Inc (US) Company Information
11.3.2 Meda Consumer Healthcare Inc (US) Insomnia Pharmacological Treatment Product Offered
11.3.3 Meda Consumer Healthcare Inc (US) Insomnia Pharmacological Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Meda Consumer Healthcare Inc (US) Main Business Overview
11.3.5 Meda Consumer Healthcare Inc (US) Latest Developments
11.4 Pfizer, Inc (US)
11.4.1 Pfizer, Inc (US) Company Information
11.4.2 Pfizer, Inc (US) Insomnia Pharmacological Treatment Product Offered
11.4.3 Pfizer, Inc (US) Insomnia Pharmacological Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Pfizer, Inc (US) Main Business Overview
11.4.5 Pfizer, Inc (US) Latest Developments
11.5 Sanofi (France)
11.5.1 Sanofi (France) Company Information
11.5.2 Sanofi (France) Insomnia Pharmacological Treatment Product Offered
11.5.3 Sanofi (France) Insomnia Pharmacological Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Sanofi (France) Main Business Overview
11.5.5 Sanofi (France) Latest Developments
11.6 Takeda Pharmaceutical Company Ltd. (Japan)
11.6.1 Takeda Pharmaceutical Company Ltd. (Japan) Company Information
11.6.2 Takeda Pharmaceutical Company Ltd. (Japan) Insomnia Pharmacological Treatment Product Offered
11.6.3 Takeda Pharmaceutical Company Ltd. (Japan) Insomnia Pharmacological Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Takeda Pharmaceutical Company Ltd. (Japan) Main Business Overview
11.6.5 Takeda Pharmaceutical Company Ltd. (Japan) Latest Developments
11.7 Pernix Therapeutics (US)
11.7.1 Pernix Therapeutics (US) Company Information
11.7.2 Pernix Therapeutics (US) Insomnia Pharmacological Treatment Product Offered
11.7.3 Pernix Therapeutics (US) Insomnia Pharmacological Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Pernix Therapeutics (US) Main Business Overview
11.7.5 Pernix Therapeutics (US) Latest Developments
11.8 Purdue Pharma L.P (US)
11.8.1 Purdue Pharma L.P (US) Company Information
11.8.2 Purdue Pharma L.P (US) Insomnia Pharmacological Treatment Product Offered
11.8.3 Purdue Pharma L.P (US) Insomnia Pharmacological Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Purdue Pharma L.P (US) Main Business Overview
11.8.5 Purdue Pharma L.P (US) Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Insomnia PharmacologicalTreatment Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Insomnia PharmacologicalTreatment Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Prescription Sleep Aids
Table 4. Major Players of Over-the-Counter Sleep Aids
Table 5. Insomnia PharmacologicalTreatment Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Insomnia PharmacologicalTreatment Market Size byType (2020-2025) & ($ millions)
Table 7. Global Insomnia PharmacologicalTreatment Market Size Market Share byType (2020-2025)
Table 8. Insomnia PharmacologicalTreatment Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Insomnia PharmacologicalTreatment Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Insomnia PharmacologicalTreatment Market Size Market Share by Application (2020-2025)
Table 11. Global Insomnia PharmacologicalTreatment Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Insomnia PharmacologicalTreatment Revenue Market Share by Player (2020-2025)
Table 13. Insomnia PharmacologicalTreatment Key Players Head office and Products Offered
Table 14. Insomnia PharmacologicalTreatment Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Insomnia PharmacologicalTreatment Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Insomnia PharmacologicalTreatment Market Size Market Share by Region (2020-2025)
Table 19. Global Insomnia PharmacologicalTreatment Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Insomnia PharmacologicalTreatment Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Insomnia PharmacologicalTreatment Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Insomnia PharmacologicalTreatment Market Size Market Share by Country (2020-2025)
Table 23. Americas Insomnia PharmacologicalTreatment Market Size byType (2020-2025) & ($ millions)
Table 24. Americas Insomnia PharmacologicalTreatment Market Size Market Share byType (2020-2025)
Table 25. Americas Insomnia PharmacologicalTreatment Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Insomnia PharmacologicalTreatment Market Size Market Share by Application (2020-2025)
Table 27. APAC Insomnia PharmacologicalTreatment Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Insomnia PharmacologicalTreatment Market Size Market Share by Region (2020-2025)
Table 29. APAC Insomnia PharmacologicalTreatment Market Size byType (2020-2025) & ($ millions)
Table 30. APAC Insomnia PharmacologicalTreatment Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Insomnia PharmacologicalTreatment Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Insomnia PharmacologicalTreatment Market Size Market Share by Country (2020-2025)
Table 33. Europe Insomnia PharmacologicalTreatment Market Size byType (2020-2025) & ($ millions)
Table 34. Europe Insomnia PharmacologicalTreatment Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Insomnia PharmacologicalTreatment Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Insomnia PharmacologicalTreatment Market Size byType (2020-2025) & ($ millions)
Table 37. Middle East & Africa Insomnia PharmacologicalTreatment Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Insomnia PharmacologicalTreatment
Table 39. Key Market Challenges & Risks of Insomnia PharmacologicalTreatment
Table 40. Key IndustryTrends of Insomnia PharmacologicalTreatment
Table 41. Global Insomnia PharmacologicalTreatment Market SizeForecast by Region (2026-2031) & ($ millions)
Table 42. Global Insomnia PharmacologicalTreatment Market Size Market ShareForecast by Region (2026-2031)
Table 43. Global Insomnia PharmacologicalTreatment Market SizeForecast byType (2026-2031) & ($ millions)
Table 44. Global Insomnia PharmacologicalTreatment Market SizeForecast by Application (2026-2031) & ($ millions)
Table 45. Eisai, Co. Ltd. (Japan) Details, CompanyType, Insomnia PharmacologicalTreatment Area Served and Its Competitors
Table 46. Eisai, Co. Ltd. (Japan) Insomnia PharmacologicalTreatment Product Offered
Table 47. Eisai, Co. Ltd. (Japan) Insomnia PharmacologicalTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Eisai, Co. Ltd. (Japan) Main Business
Table 49. Eisai, Co. Ltd. (Japan) Latest Developments
Table 50. Merck & Co., Inc (US) Details, CompanyType, Insomnia PharmacologicalTreatment Area Served and Its Competitors
Table 51. Merck & Co., Inc (US) Insomnia PharmacologicalTreatment Product Offered
Table 52. Merck & Co., Inc (US) Insomnia PharmacologicalTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Merck & Co., Inc (US) Main Business
Table 54. Merck & Co., Inc (US) Latest Developments
Table 55. Meda Consumer Healthcare Inc (US) Details, CompanyType, Insomnia PharmacologicalTreatment Area Served and Its Competitors
Table 56. Meda Consumer Healthcare Inc (US) Insomnia PharmacologicalTreatment Product Offered
Table 57. Meda Consumer Healthcare Inc (US) Insomnia PharmacologicalTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Meda Consumer Healthcare Inc (US) Main Business
Table 59. Meda Consumer Healthcare Inc (US) Latest Developments
Table 60. Pfizer, Inc (US) Details, CompanyType, Insomnia PharmacologicalTreatment Area Served and Its Competitors
Table 61. Pfizer, Inc (US) Insomnia PharmacologicalTreatment Product Offered
Table 62. Pfizer, Inc (US) Insomnia PharmacologicalTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Pfizer, Inc (US) Main Business
Table 64. Pfizer, Inc (US) Latest Developments
Table 65. Sanofi (France) Details, CompanyType, Insomnia PharmacologicalTreatment Area Served and Its Competitors
Table 66. Sanofi (France) Insomnia PharmacologicalTreatment Product Offered
Table 67. Sanofi (France) Insomnia PharmacologicalTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Sanofi (France) Main Business
Table 69. Sanofi (France) Latest Developments
Table 70.Takeda Pharmaceutical Company Ltd. (Japan) Details, CompanyType, Insomnia PharmacologicalTreatment Area Served and Its Competitors
Table 71.Takeda Pharmaceutical Company Ltd. (Japan) Insomnia PharmacologicalTreatment Product Offered
Table 72.Takeda Pharmaceutical Company Ltd. (Japan) Insomnia PharmacologicalTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73.Takeda Pharmaceutical Company Ltd. (Japan) Main Business
Table 74.Takeda Pharmaceutical Company Ltd. (Japan) Latest Developments
Table 75. PernixTherapeutics (US) Details, CompanyType, Insomnia PharmacologicalTreatment Area Served and Its Competitors
Table 76. PernixTherapeutics (US) Insomnia PharmacologicalTreatment Product Offered
Table 77. PernixTherapeutics (US) Insomnia PharmacologicalTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. PernixTherapeutics (US) Main Business
Table 79. PernixTherapeutics (US) Latest Developments
Table 80. Purdue Pharma L.P (US) Details, CompanyType, Insomnia PharmacologicalTreatment Area Served and Its Competitors
Table 81. Purdue Pharma L.P (US) Insomnia PharmacologicalTreatment Product Offered
Table 82. Purdue Pharma L.P (US) Insomnia PharmacologicalTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Purdue Pharma L.P (US) Main Business
Table 84. Purdue Pharma L.P (US) Latest Developments
LIST OFFIGURES
Figure 1. Insomnia PharmacologicalTreatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Insomnia PharmacologicalTreatment Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Insomnia PharmacologicalTreatment Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Insomnia PharmacologicalTreatment Sales Market Share by Country/Region (2024)
Figure 8. Insomnia PharmacologicalTreatment Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Insomnia PharmacologicalTreatment Market Size Market Share byType in 2024
Figure 10. Insomnia PharmacologicalTreatment in Homecare
Figure 11. Global Insomnia PharmacologicalTreatment Market: Homecare (2020-2025) & ($ millions)
Figure 12. Insomnia PharmacologicalTreatment in Clinic
Figure 13. Global Insomnia PharmacologicalTreatment Market: Clinic (2020-2025) & ($ millions)
Figure 14. Insomnia PharmacologicalTreatment in Hospital
Figure 15. Global Insomnia PharmacologicalTreatment Market: Hospital (2020-2025) & ($ millions)
Figure 16. Global Insomnia PharmacologicalTreatment Market Size Market Share by Application in 2024
Figure 17. Global Insomnia PharmacologicalTreatment Revenue Market Share by Player in 2024
Figure 18. Global Insomnia PharmacologicalTreatment Market Size Market Share by Region (2020-2025)
Figure 19. Americas Insomnia PharmacologicalTreatment Market Size 2020-2025 ($ millions)
Figure 20. APAC Insomnia PharmacologicalTreatment Market Size 2020-2025 ($ millions)
Figure 21. Europe Insomnia PharmacologicalTreatment Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Insomnia PharmacologicalTreatment Market Size 2020-2025 ($ millions)
Figure 23. Americas Insomnia PharmacologicalTreatment Value Market Share by Country in 2024
Figure 24. United States Insomnia PharmacologicalTreatment Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Insomnia PharmacologicalTreatment Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Insomnia PharmacologicalTreatment Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Insomnia PharmacologicalTreatment Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Insomnia PharmacologicalTreatment Market Size Market Share by Region in 2024
Figure 29. APAC Insomnia PharmacologicalTreatment Market Size Market Share byType (2020-2025)
Figure 30. APAC Insomnia PharmacologicalTreatment Market Size Market Share by Application (2020-2025)
Figure 31. China Insomnia PharmacologicalTreatment Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Insomnia PharmacologicalTreatment Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Insomnia PharmacologicalTreatment Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Insomnia PharmacologicalTreatment Market Size Growth 2020-2025 ($ millions)
Figure 35. India Insomnia PharmacologicalTreatment Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Insomnia PharmacologicalTreatment Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Insomnia PharmacologicalTreatment Market Size Market Share by Country in 2024
Figure 38. Europe Insomnia PharmacologicalTreatment Market Size Market Share byType (2020-2025)
Figure 39. Europe Insomnia PharmacologicalTreatment Market Size Market Share by Application (2020-2025)
Figure 40. Germany Insomnia PharmacologicalTreatment Market Size Growth 2020-2025 ($ millions)
Figure 41.France Insomnia PharmacologicalTreatment Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Insomnia PharmacologicalTreatment Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Insomnia PharmacologicalTreatment Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Insomnia PharmacologicalTreatment Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Insomnia PharmacologicalTreatment Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Insomnia PharmacologicalTreatment Market Size Market Share byType (2020-2025)
Figure 47. Middle East & Africa Insomnia PharmacologicalTreatment Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Insomnia PharmacologicalTreatment Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Insomnia PharmacologicalTreatment Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Insomnia PharmacologicalTreatment Market Size Growth 2020-2025 ($ millions)
Figure 51.Turkey Insomnia PharmacologicalTreatment Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Insomnia PharmacologicalTreatment Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Insomnia PharmacologicalTreatment Market Size 2026-2031 ($ millions)
Figure 54. APAC Insomnia PharmacologicalTreatment Market Size 2026-2031 ($ millions)
Figure 55. Europe Insomnia PharmacologicalTreatment Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Insomnia PharmacologicalTreatment Market Size 2026-2031 ($ millions)
Figure 57. United States Insomnia PharmacologicalTreatment Market Size 2026-2031 ($ millions)
Figure 58. Canada Insomnia PharmacologicalTreatment Market Size 2026-2031 ($ millions)
Figure 59. Mexico Insomnia PharmacologicalTreatment Market Size 2026-2031 ($ millions)
Figure 60. Brazil Insomnia PharmacologicalTreatment Market Size 2026-2031 ($ millions)
Figure 61. China Insomnia PharmacologicalTreatment Market Size 2026-2031 ($ millions)
Figure 62. Japan Insomnia PharmacologicalTreatment Market Size 2026-2031 ($ millions)
Figure 63. Korea Insomnia PharmacologicalTreatment Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Insomnia PharmacologicalTreatment Market Size 2026-2031 ($ millions)
Figure 65. India Insomnia PharmacologicalTreatment Market Size 2026-2031 ($ millions)
Figure 66. Australia Insomnia PharmacologicalTreatment Market Size 2026-2031 ($ millions)
Figure 67. Germany Insomnia PharmacologicalTreatment Market Size 2026-2031 ($ millions)
Figure 68.France Insomnia PharmacologicalTreatment Market Size 2026-2031 ($ millions)
Figure 69. UK Insomnia PharmacologicalTreatment Market Size 2026-2031 ($ millions)
Figure 70. Italy Insomnia PharmacologicalTreatment Market Size 2026-2031 ($ millions)
Figure 71. Russia Insomnia PharmacologicalTreatment Market Size 2026-2031 ($ millions)
Figure 72. Egypt Insomnia PharmacologicalTreatment Market Size 2026-2031 ($ millions)
Figure 73. South Africa Insomnia PharmacologicalTreatment Market Size 2026-2031 ($ millions)
Figure 74. Israel Insomnia PharmacologicalTreatment Market Size 2026-2031 ($ millions)
Figure 75.Turkey Insomnia PharmacologicalTreatment Market Size 2026-2031 ($ millions)
Figure 76. Global Insomnia PharmacologicalTreatment Market Size Market ShareForecast byType (2026-2031)
Figure 77. Global Insomnia PharmacologicalTreatment Market Size Market ShareForecast by Application (2026-2031)
Figure 78. GCC Countries Insomnia PharmacologicalTreatment Market Size 2026-2031 ($ millions)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Insomnia Pharmacological Treatment Market Size (2020-2031)
2.1.2 Insomnia Pharmacological Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Insomnia Pharmacological Treatment by Country/Region (2020, 2024 & 2031)
2.2 Insomnia Pharmacological Treatment Segment by Type
2.2.1 Prescription Sleep Aids
2.2.2 Over-the-Counter Sleep Aids
2.3 Insomnia Pharmacological Treatment Market Size by Type
2.3.1 Insomnia Pharmacological Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Insomnia Pharmacological Treatment Market Size Market Share by Type (2020-2025)
2.4 Insomnia Pharmacological Treatment Segment by Application
2.4.1 Homecare
2.4.2 Clinic
2.4.3 Hospital
2.5 Insomnia Pharmacological Treatment Market Size by Application
2.5.1 Insomnia Pharmacological Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Insomnia Pharmacological Treatment Market Size Market Share by Application (2020-2025)
3 INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE BY PLAYER
3.1 Insomnia Pharmacological Treatment Market Size Market Share by Player
3.1.1 Global Insomnia Pharmacological Treatment Revenue by Player (2020-2025)
3.1.2 Global Insomnia Pharmacological Treatment Revenue Market Share by Player (2020-2025)
3.2 Global Insomnia Pharmacological Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 INSOMNIA PHARMACOLOGICAL TREATMENT BY REGION
4.1 Insomnia Pharmacological Treatment Market Size by Region (2020-2025)
4.2 Global Insomnia Pharmacological Treatment Annual Revenue by Country/Region (2020-2025)
4.3 Americas Insomnia Pharmacological Treatment Market Size Growth (2020-2025)
4.4 APAC Insomnia Pharmacological Treatment Market Size Growth (2020-2025)
4.5 Europe Insomnia Pharmacological Treatment Market Size Growth (2020-2025)
4.6 Middle East & Africa Insomnia Pharmacological Treatment Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Insomnia Pharmacological Treatment Market Size by Country (2020-2025)
5.2 Americas Insomnia Pharmacological Treatment Market Size by Type (2020-2025)
5.3 Americas Insomnia Pharmacological Treatment Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Insomnia Pharmacological Treatment Market Size by Region (2020-2025)
6.2 APAC Insomnia Pharmacological Treatment Market Size by Type (2020-2025)
6.3 APAC Insomnia Pharmacological Treatment Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Insomnia Pharmacological Treatment Market Size by Country (2020-2025)
7.2 Europe Insomnia Pharmacological Treatment Market Size by Type (2020-2025)
7.3 Europe Insomnia Pharmacological Treatment Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Insomnia Pharmacological Treatment by Region (2020-2025)
8.2 Middle East & Africa Insomnia Pharmacological Treatment Market Size by Type (2020-2025)
8.3 Middle East & Africa Insomnia Pharmacological Treatment Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET FORECAST
10.1 Global Insomnia Pharmacological Treatment Forecast by Region (2026-2031)
10.1.1 Global Insomnia Pharmacological Treatment Forecast by Region (2026-2031)
10.1.2 Americas Insomnia Pharmacological Treatment Forecast
10.1.3 APAC Insomnia Pharmacological Treatment Forecast
10.1.4 Europe Insomnia Pharmacological Treatment Forecast
10.1.5 Middle East & Africa Insomnia Pharmacological Treatment Forecast
10.2 Americas Insomnia Pharmacological Treatment Forecast by Country (2026-2031)
10.2.1 United States Market Insomnia Pharmacological Treatment Forecast
10.2.2 Canada Market Insomnia Pharmacological Treatment Forecast
10.2.3 Mexico Market Insomnia Pharmacological Treatment Forecast
10.2.4 Brazil Market Insomnia Pharmacological Treatment Forecast
10.3 APAC Insomnia Pharmacological Treatment Forecast by Region (2026-2031)
10.3.1 China Insomnia Pharmacological Treatment Market Forecast
10.3.2 Japan Market Insomnia Pharmacological Treatment Forecast
10.3.3 Korea Market Insomnia Pharmacological Treatment Forecast
10.3.4 Southeast Asia Market Insomnia Pharmacological Treatment Forecast
10.3.5 India Market Insomnia Pharmacological Treatment Forecast
10.3.6 Australia Market Insomnia Pharmacological Treatment Forecast
10.4 Europe Insomnia Pharmacological Treatment Forecast by Country (2026-2031)
10.4.1 Germany Market Insomnia Pharmacological Treatment Forecast
10.4.2 France Market Insomnia Pharmacological Treatment Forecast
10.4.3 UK Market Insomnia Pharmacological Treatment Forecast
10.4.4 Italy Market Insomnia Pharmacological Treatment Forecast
10.4.5 Russia Market Insomnia Pharmacological Treatment Forecast
10.5 Middle East & Africa Insomnia Pharmacological Treatment Forecast by Region (2026-2031)
10.5.1 Egypt Market Insomnia Pharmacological Treatment Forecast
10.5.2 South Africa Market Insomnia Pharmacological Treatment Forecast
10.5.3 Israel Market Insomnia Pharmacological Treatment Forecast
10.5.4 Turkey Market Insomnia Pharmacological Treatment Forecast
10.6 Global Insomnia Pharmacological Treatment Forecast by Type (2026-2031)
10.7 Global Insomnia Pharmacological Treatment Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Insomnia Pharmacological Treatment Forecast
11 KEY PLAYERS ANALYSIS
11.1 Eisai, Co. Ltd. (Japan)
11.1.1 Eisai, Co. Ltd. (Japan) Company Information
11.1.2 Eisai, Co. Ltd. (Japan) Insomnia Pharmacological Treatment Product Offered
11.1.3 Eisai, Co. Ltd. (Japan) Insomnia Pharmacological Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Eisai, Co. Ltd. (Japan) Main Business Overview
11.1.5 Eisai, Co. Ltd. (Japan) Latest Developments
11.2 Merck & Co., Inc (US)
11.2.1 Merck & Co., Inc (US) Company Information
11.2.2 Merck & Co., Inc (US) Insomnia Pharmacological Treatment Product Offered
11.2.3 Merck & Co., Inc (US) Insomnia Pharmacological Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Merck & Co., Inc (US) Main Business Overview
11.2.5 Merck & Co., Inc (US) Latest Developments
11.3 Meda Consumer Healthcare Inc (US)
11.3.1 Meda Consumer Healthcare Inc (US) Company Information
11.3.2 Meda Consumer Healthcare Inc (US) Insomnia Pharmacological Treatment Product Offered
11.3.3 Meda Consumer Healthcare Inc (US) Insomnia Pharmacological Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Meda Consumer Healthcare Inc (US) Main Business Overview
11.3.5 Meda Consumer Healthcare Inc (US) Latest Developments
11.4 Pfizer, Inc (US)
11.4.1 Pfizer, Inc (US) Company Information
11.4.2 Pfizer, Inc (US) Insomnia Pharmacological Treatment Product Offered
11.4.3 Pfizer, Inc (US) Insomnia Pharmacological Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Pfizer, Inc (US) Main Business Overview
11.4.5 Pfizer, Inc (US) Latest Developments
11.5 Sanofi (France)
11.5.1 Sanofi (France) Company Information
11.5.2 Sanofi (France) Insomnia Pharmacological Treatment Product Offered
11.5.3 Sanofi (France) Insomnia Pharmacological Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Sanofi (France) Main Business Overview
11.5.5 Sanofi (France) Latest Developments
11.6 Takeda Pharmaceutical Company Ltd. (Japan)
11.6.1 Takeda Pharmaceutical Company Ltd. (Japan) Company Information
11.6.2 Takeda Pharmaceutical Company Ltd. (Japan) Insomnia Pharmacological Treatment Product Offered
11.6.3 Takeda Pharmaceutical Company Ltd. (Japan) Insomnia Pharmacological Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Takeda Pharmaceutical Company Ltd. (Japan) Main Business Overview
11.6.5 Takeda Pharmaceutical Company Ltd. (Japan) Latest Developments
11.7 Pernix Therapeutics (US)
11.7.1 Pernix Therapeutics (US) Company Information
11.7.2 Pernix Therapeutics (US) Insomnia Pharmacological Treatment Product Offered
11.7.3 Pernix Therapeutics (US) Insomnia Pharmacological Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Pernix Therapeutics (US) Main Business Overview
11.7.5 Pernix Therapeutics (US) Latest Developments
11.8 Purdue Pharma L.P (US)
11.8.1 Purdue Pharma L.P (US) Company Information
11.8.2 Purdue Pharma L.P (US) Insomnia Pharmacological Treatment Product Offered
11.8.3 Purdue Pharma L.P (US) Insomnia Pharmacological Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Purdue Pharma L.P (US) Main Business Overview
11.8.5 Purdue Pharma L.P (US) Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Insomnia PharmacologicalTreatment Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Insomnia PharmacologicalTreatment Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Prescription Sleep Aids
Table 4. Major Players of Over-the-Counter Sleep Aids
Table 5. Insomnia PharmacologicalTreatment Market Size CAGR byType (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Insomnia PharmacologicalTreatment Market Size byType (2020-2025) & ($ millions)
Table 7. Global Insomnia PharmacologicalTreatment Market Size Market Share byType (2020-2025)
Table 8. Insomnia PharmacologicalTreatment Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Insomnia PharmacologicalTreatment Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Insomnia PharmacologicalTreatment Market Size Market Share by Application (2020-2025)
Table 11. Global Insomnia PharmacologicalTreatment Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Insomnia PharmacologicalTreatment Revenue Market Share by Player (2020-2025)
Table 13. Insomnia PharmacologicalTreatment Key Players Head office and Products Offered
Table 14. Insomnia PharmacologicalTreatment Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Insomnia PharmacologicalTreatment Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Insomnia PharmacologicalTreatment Market Size Market Share by Region (2020-2025)
Table 19. Global Insomnia PharmacologicalTreatment Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Insomnia PharmacologicalTreatment Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Insomnia PharmacologicalTreatment Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Insomnia PharmacologicalTreatment Market Size Market Share by Country (2020-2025)
Table 23. Americas Insomnia PharmacologicalTreatment Market Size byType (2020-2025) & ($ millions)
Table 24. Americas Insomnia PharmacologicalTreatment Market Size Market Share byType (2020-2025)
Table 25. Americas Insomnia PharmacologicalTreatment Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Insomnia PharmacologicalTreatment Market Size Market Share by Application (2020-2025)
Table 27. APAC Insomnia PharmacologicalTreatment Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Insomnia PharmacologicalTreatment Market Size Market Share by Region (2020-2025)
Table 29. APAC Insomnia PharmacologicalTreatment Market Size byType (2020-2025) & ($ millions)
Table 30. APAC Insomnia PharmacologicalTreatment Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Insomnia PharmacologicalTreatment Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Insomnia PharmacologicalTreatment Market Size Market Share by Country (2020-2025)
Table 33. Europe Insomnia PharmacologicalTreatment Market Size byType (2020-2025) & ($ millions)
Table 34. Europe Insomnia PharmacologicalTreatment Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Insomnia PharmacologicalTreatment Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Insomnia PharmacologicalTreatment Market Size byType (2020-2025) & ($ millions)
Table 37. Middle East & Africa Insomnia PharmacologicalTreatment Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Insomnia PharmacologicalTreatment
Table 39. Key Market Challenges & Risks of Insomnia PharmacologicalTreatment
Table 40. Key IndustryTrends of Insomnia PharmacologicalTreatment
Table 41. Global Insomnia PharmacologicalTreatment Market SizeForecast by Region (2026-2031) & ($ millions)
Table 42. Global Insomnia PharmacologicalTreatment Market Size Market ShareForecast by Region (2026-2031)
Table 43. Global Insomnia PharmacologicalTreatment Market SizeForecast byType (2026-2031) & ($ millions)
Table 44. Global Insomnia PharmacologicalTreatment Market SizeForecast by Application (2026-2031) & ($ millions)
Table 45. Eisai, Co. Ltd. (Japan) Details, CompanyType, Insomnia PharmacologicalTreatment Area Served and Its Competitors
Table 46. Eisai, Co. Ltd. (Japan) Insomnia PharmacologicalTreatment Product Offered
Table 47. Eisai, Co. Ltd. (Japan) Insomnia PharmacologicalTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Eisai, Co. Ltd. (Japan) Main Business
Table 49. Eisai, Co. Ltd. (Japan) Latest Developments
Table 50. Merck & Co., Inc (US) Details, CompanyType, Insomnia PharmacologicalTreatment Area Served and Its Competitors
Table 51. Merck & Co., Inc (US) Insomnia PharmacologicalTreatment Product Offered
Table 52. Merck & Co., Inc (US) Insomnia PharmacologicalTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Merck & Co., Inc (US) Main Business
Table 54. Merck & Co., Inc (US) Latest Developments
Table 55. Meda Consumer Healthcare Inc (US) Details, CompanyType, Insomnia PharmacologicalTreatment Area Served and Its Competitors
Table 56. Meda Consumer Healthcare Inc (US) Insomnia PharmacologicalTreatment Product Offered
Table 57. Meda Consumer Healthcare Inc (US) Insomnia PharmacologicalTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Meda Consumer Healthcare Inc (US) Main Business
Table 59. Meda Consumer Healthcare Inc (US) Latest Developments
Table 60. Pfizer, Inc (US) Details, CompanyType, Insomnia PharmacologicalTreatment Area Served and Its Competitors
Table 61. Pfizer, Inc (US) Insomnia PharmacologicalTreatment Product Offered
Table 62. Pfizer, Inc (US) Insomnia PharmacologicalTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Pfizer, Inc (US) Main Business
Table 64. Pfizer, Inc (US) Latest Developments
Table 65. Sanofi (France) Details, CompanyType, Insomnia PharmacologicalTreatment Area Served and Its Competitors
Table 66. Sanofi (France) Insomnia PharmacologicalTreatment Product Offered
Table 67. Sanofi (France) Insomnia PharmacologicalTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Sanofi (France) Main Business
Table 69. Sanofi (France) Latest Developments
Table 70.Takeda Pharmaceutical Company Ltd. (Japan) Details, CompanyType, Insomnia PharmacologicalTreatment Area Served and Its Competitors
Table 71.Takeda Pharmaceutical Company Ltd. (Japan) Insomnia PharmacologicalTreatment Product Offered
Table 72.Takeda Pharmaceutical Company Ltd. (Japan) Insomnia PharmacologicalTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73.Takeda Pharmaceutical Company Ltd. (Japan) Main Business
Table 74.Takeda Pharmaceutical Company Ltd. (Japan) Latest Developments
Table 75. PernixTherapeutics (US) Details, CompanyType, Insomnia PharmacologicalTreatment Area Served and Its Competitors
Table 76. PernixTherapeutics (US) Insomnia PharmacologicalTreatment Product Offered
Table 77. PernixTherapeutics (US) Insomnia PharmacologicalTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. PernixTherapeutics (US) Main Business
Table 79. PernixTherapeutics (US) Latest Developments
Table 80. Purdue Pharma L.P (US) Details, CompanyType, Insomnia PharmacologicalTreatment Area Served and Its Competitors
Table 81. Purdue Pharma L.P (US) Insomnia PharmacologicalTreatment Product Offered
Table 82. Purdue Pharma L.P (US) Insomnia PharmacologicalTreatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Purdue Pharma L.P (US) Main Business
Table 84. Purdue Pharma L.P (US) Latest Developments
LIST OFFIGURES
Figure 1. Insomnia PharmacologicalTreatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Insomnia PharmacologicalTreatment Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Insomnia PharmacologicalTreatment Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Insomnia PharmacologicalTreatment Sales Market Share by Country/Region (2024)
Figure 8. Insomnia PharmacologicalTreatment Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Insomnia PharmacologicalTreatment Market Size Market Share byType in 2024
Figure 10. Insomnia PharmacologicalTreatment in Homecare
Figure 11. Global Insomnia PharmacologicalTreatment Market: Homecare (2020-2025) & ($ millions)
Figure 12. Insomnia PharmacologicalTreatment in Clinic
Figure 13. Global Insomnia PharmacologicalTreatment Market: Clinic (2020-2025) & ($ millions)
Figure 14. Insomnia PharmacologicalTreatment in Hospital
Figure 15. Global Insomnia PharmacologicalTreatment Market: Hospital (2020-2025) & ($ millions)
Figure 16. Global Insomnia PharmacologicalTreatment Market Size Market Share by Application in 2024
Figure 17. Global Insomnia PharmacologicalTreatment Revenue Market Share by Player in 2024
Figure 18. Global Insomnia PharmacologicalTreatment Market Size Market Share by Region (2020-2025)
Figure 19. Americas Insomnia PharmacologicalTreatment Market Size 2020-2025 ($ millions)
Figure 20. APAC Insomnia PharmacologicalTreatment Market Size 2020-2025 ($ millions)
Figure 21. Europe Insomnia PharmacologicalTreatment Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Insomnia PharmacologicalTreatment Market Size 2020-2025 ($ millions)
Figure 23. Americas Insomnia PharmacologicalTreatment Value Market Share by Country in 2024
Figure 24. United States Insomnia PharmacologicalTreatment Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Insomnia PharmacologicalTreatment Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Insomnia PharmacologicalTreatment Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Insomnia PharmacologicalTreatment Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Insomnia PharmacologicalTreatment Market Size Market Share by Region in 2024
Figure 29. APAC Insomnia PharmacologicalTreatment Market Size Market Share byType (2020-2025)
Figure 30. APAC Insomnia PharmacologicalTreatment Market Size Market Share by Application (2020-2025)
Figure 31. China Insomnia PharmacologicalTreatment Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Insomnia PharmacologicalTreatment Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Insomnia PharmacologicalTreatment Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Insomnia PharmacologicalTreatment Market Size Growth 2020-2025 ($ millions)
Figure 35. India Insomnia PharmacologicalTreatment Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Insomnia PharmacologicalTreatment Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Insomnia PharmacologicalTreatment Market Size Market Share by Country in 2024
Figure 38. Europe Insomnia PharmacologicalTreatment Market Size Market Share byType (2020-2025)
Figure 39. Europe Insomnia PharmacologicalTreatment Market Size Market Share by Application (2020-2025)
Figure 40. Germany Insomnia PharmacologicalTreatment Market Size Growth 2020-2025 ($ millions)
Figure 41.France Insomnia PharmacologicalTreatment Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Insomnia PharmacologicalTreatment Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Insomnia PharmacologicalTreatment Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Insomnia PharmacologicalTreatment Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Insomnia PharmacologicalTreatment Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Insomnia PharmacologicalTreatment Market Size Market Share byType (2020-2025)
Figure 47. Middle East & Africa Insomnia PharmacologicalTreatment Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Insomnia PharmacologicalTreatment Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Insomnia PharmacologicalTreatment Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Insomnia PharmacologicalTreatment Market Size Growth 2020-2025 ($ millions)
Figure 51.Turkey Insomnia PharmacologicalTreatment Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Insomnia PharmacologicalTreatment Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Insomnia PharmacologicalTreatment Market Size 2026-2031 ($ millions)
Figure 54. APAC Insomnia PharmacologicalTreatment Market Size 2026-2031 ($ millions)
Figure 55. Europe Insomnia PharmacologicalTreatment Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Insomnia PharmacologicalTreatment Market Size 2026-2031 ($ millions)
Figure 57. United States Insomnia PharmacologicalTreatment Market Size 2026-2031 ($ millions)
Figure 58. Canada Insomnia PharmacologicalTreatment Market Size 2026-2031 ($ millions)
Figure 59. Mexico Insomnia PharmacologicalTreatment Market Size 2026-2031 ($ millions)
Figure 60. Brazil Insomnia PharmacologicalTreatment Market Size 2026-2031 ($ millions)
Figure 61. China Insomnia PharmacologicalTreatment Market Size 2026-2031 ($ millions)
Figure 62. Japan Insomnia PharmacologicalTreatment Market Size 2026-2031 ($ millions)
Figure 63. Korea Insomnia PharmacologicalTreatment Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Insomnia PharmacologicalTreatment Market Size 2026-2031 ($ millions)
Figure 65. India Insomnia PharmacologicalTreatment Market Size 2026-2031 ($ millions)
Figure 66. Australia Insomnia PharmacologicalTreatment Market Size 2026-2031 ($ millions)
Figure 67. Germany Insomnia PharmacologicalTreatment Market Size 2026-2031 ($ millions)
Figure 68.France Insomnia PharmacologicalTreatment Market Size 2026-2031 ($ millions)
Figure 69. UK Insomnia PharmacologicalTreatment Market Size 2026-2031 ($ millions)
Figure 70. Italy Insomnia PharmacologicalTreatment Market Size 2026-2031 ($ millions)
Figure 71. Russia Insomnia PharmacologicalTreatment Market Size 2026-2031 ($ millions)
Figure 72. Egypt Insomnia PharmacologicalTreatment Market Size 2026-2031 ($ millions)
Figure 73. South Africa Insomnia PharmacologicalTreatment Market Size 2026-2031 ($ millions)
Figure 74. Israel Insomnia PharmacologicalTreatment Market Size 2026-2031 ($ millions)
Figure 75.Turkey Insomnia PharmacologicalTreatment Market Size 2026-2031 ($ millions)
Figure 76. Global Insomnia PharmacologicalTreatment Market Size Market ShareForecast byType (2026-2031)
Figure 77. Global Insomnia PharmacologicalTreatment Market Size Market ShareForecast by Application (2026-2031)
Figure 78. GCC Countries Insomnia PharmacologicalTreatment Market Size 2026-2031 ($ millions)
More Publications
Global Hygiene Packaging Film Market Growth 2024-2030
US$ 3,660.00
December 2024
88 pages
Global Oil & Gas Well Cement Additive Market Growth 2023-2029
US$ 3,660.00
March 2023
107 pages
Global Barium Hydroxide Market Growth 2025-2031
US$ 3,660.00
January 2025
115 pages
Global Desiccators Market Growth 2024-2030
US$ 3,660.00
February 2024
92 pages
Global Alumina-Silica Insulation Market Growth 2025-2031
US$ 3,660.00
October 2025
82 pages
